Afif Budi Andy B
Afif Budi Andy B has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Kusnaeni Kusnaeni
Institut Teknologi Bacharuddin Jusuf Habibie
2 shared publications - Rahmatullah Rahmatullah2 shared publications
- Agus Mohamad Soleh
IPB University
1 shared publication - Bagus Sartono
IPB University
1 shared publication - Fitriagustiani Fitriagustiani
Institut Teknologi dan Kesehatan Muhammadiyah Kalimantan Barat
1 shared publication Mega Sartika Hafid
1 shared publication
Latest Publications
- Open Access
- 17 August 2026
- Published by Elsevier in SSRN Electronic Journal
A Hybrid ChemBERTa–Morgan XGBoost Ensemble for Computational Multi-Endpoint Toxicity Prioritization of Blumea balsamifera Compounds
Biological investigations of Blumea balsamifera remain dominated by extract or fraction-based testing; consequently, the activities of individual compounds across various biological mechanisms have not been consistently characterized. This study developed a computational framework to prioritize 31 Blumea balsamifera compounds based on their predicted activities across 12 Tox21 endpoints. The framework integrates Morgan fingerprints, RDKit descriptors, and ChemBERTa embeddings through two endpoint-specific XGBoost branches combined using an equal-weight soft voting ensemble of calibrated probabilities. The models were developed using 7,820 Tox21 structures after three structures identical to the target compounds were excluded. Evaluation was performed using repeated five-fold scaffold cross-validation, Platt scaling, endpoint-specific thresholds, and applicability domain analysis. The ensemble achieved mean ROC-AUC, average precision, balanced accuracy, and MCC values of 0.784±0.063, 0.372±0.130, 0.712±0.052, and 0.273±0.103, respectively. Luteolin-7-methyl-ether ranked highest, with a score of 37.10 and predicted activity at 11 endpoints. This framework supports the selection of compounds for more targeted biological validation.• Develops a hybrid framework for computational prioritization of toxicity-related activity across 12 Tox21 endpoints.• Integrates Morgan fingerprints, RDKit descriptors, and ChemBERTa embeddings into a calibrated XGBoost ensemble.• Identifies luteolin-7-methyl ether as the highest priority candidate for multi-endpoint biological validation.
- 17 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessA Hybrid ChemBERTa–Morgan XGBoost Ensemble for Computational Multi-Endpoint Toxicity Prioritization of Blumea balsamifera Compounds
Biological investigations of Blumea balsamifera remain dominated by extract or fraction-based testing; consequently, the activities of individual compounds across various biological mechanisms have not been consistently characterized. This study developed a computational framework to prioritize 31 Blumea balsamifera compounds based on their predicted activities across 12 Tox21 endpoints. The framework integrates Morgan fingerprints, RDKit descriptors, and ChemBERTa embeddings through two endpoint-specific XGBoost branches combined using an equal-weight soft voting ensemble of calibrated probabilities. The models were developed using 7,820 Tox21 structures after three structures identical to the target compounds were excluded. Evaluation was performed using repeated five-fold scaffold cross-validation, Platt scaling, endpoint-specific thresholds, and applicability domain analysis. The ensemble achieved mean ROC-AUC, average precision, balanced accuracy, and MCC values of 0.784±0.063, 0.372±0.130, 0.712±0.052, and 0.273±0.103, respectively. Luteolin-7-methyl-ether ranked highest, with a score of 37.10 and predicted activity at 11 endpoints. This framework supports the selection of compounds for more targeted biological validation.• Develops a hybrid framework for computational prioritization of toxicity-related activity across 12 Tox21 endpoints.• Integrates Morgan fingerprints, RDKit descriptors, and ChemBERTa embeddings into a calibrated XGBoost ensemble.• Identifies luteolin-7-methyl ether as the highest priority candidate for multi-endpoint biological validation.
- Open Access
- 20 April 2026
- Published by Universitas Muslim Indonesia in ILKOM Jurnal Ilmiah
- Vol. 18 (1)
A Hybrid Deep Learning–Machine Learning Approach for the Identification of Active Compounds in Blumea balsamifera (Sembung Leaves)
Blumea balsamifera (sembung) is a medicinal plant with well-documented antibacterial, anti-inflammatory, and analgesic properties. However, the systematic identification of its bioactive compounds remains a significant challenge due to the complexity and high dimensionality of LC–MS (Liquid Chromatography–Mass Spectrometry) data. This study aims to develop a robust computational framework for automated compound identification using a hybrid modeling approach.A hybrid model integrating Long Short-Term Memory (LSTM) and Extreme Gradient Boosting (XGBoost) was employed to enhance feature extraction and classification performance. The LSTM component was utilized to capture sequential dependencies in spectral data, while XGBoost performed optimized classification through gradient boosting. This integration enables efficient handling of complex spectral patterns and improves predictive accuracy.The proposed model achieved an accuracy of 91%, demonstrating strong performance in classifying and identifying bioactive compounds. Feature importance analysis identified several key compounds contributing to the model predictions, including Luteolin-7-methyl-ether, Umbelliferone, Blumeatin, Dihydroquercetin-7,4′-dimethylether, Chrysosplenol C, Blumealactone B, and Blumeaene E. These compounds are associated with known pharmacological activities, supporting the therapeutic relevance of B. balsamifera.The proposed hybrid LSTM–XGBoost framework provides an effective and scalable approach for LC–MS-based compound identification. This method reduces analytical complexity, enhances classification reliability, and offers a data-driven strategy for accelerating phytochemical research and bioactive compound validation
- 20 April 2026
- Published by Universitas Muslim Indonesia in ILKOM Jurnal Ilmiah
- Vol. 18 (1)
Open AccessA Hybrid Deep Learning–Machine Learning Approach for the Identification of Active Compounds in Blumea balsamifera (Sembung Leaves)
Blumea balsamifera (sembung) is a medicinal plant with well-documented antibacterial, anti-inflammatory, and analgesic properties. However, the systematic identification of its bioactive compounds remains a significant challenge due to the complexity and high dimensionality of LC–MS (Liquid Chromatography–Mass Spectrometry) data. This study aims to develop a robust computational framework for automated compound identification using a hybrid modeling approach.A hybrid model integrating Long Short-Term Memory (LSTM) and Extreme Gradient Boosting (XGBoost) was employed to enhance feature extraction and classification performance. The LSTM component was utilized to capture sequential dependencies in spectral data, while XGBoost performed optimized classification through gradient boosting. This integration enables efficient handling of complex spectral patterns and improves predictive accuracy.The proposed model achieved an accuracy of 91%, demonstrating strong performance in classifying and identifying bioactive compounds. Feature importance analysis identified several key compounds contributing to the model predictions, including Luteolin-7-methyl-ether, Umbelliferone, Blumeatin, Dihydroquercetin-7,4′-dimethylether, Chrysosplenol C, Blumealactone B, and Blumeaene E. These compounds are associated with known pharmacological activities, supporting the therapeutic relevance of B. balsamifera.The proposed hybrid LSTM–XGBoost framework provides an effective and scalable approach for LC–MS-based compound identification. This method reduces analytical complexity, enhances classification reliability, and offers a data-driven strategy for accelerating phytochemical research and bioactive compound validation